The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Trump’s latest tariff vow threatens to disrupt supplies of obesity drugs such as Mounjaro and Wegovy as pharma giants face ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

What are the most concerning side effects of Ozempic and other weight-loss drugs? - Gastrointestinal and cardiovascular complications are among the most serious side effects ...

IPL is passé, and Lok Sabha elections no longer carry the same thrill. A new battle is brewing in India, and is ready to take ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Lilly markets its dual GIP and GLP-1 receptor agonist, ...

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and ...

We’ve reached that time of year when, at the first blast of sun, women start dreading “bikini body” headlines. Celebrities ...